HHS named the members of its new Federal Coordinating Council for Comparative Effectiveness Research, established to oversee and manage $1.1 billion in research funds allocated through the American Recovery and Reinvestment Act of 2009.
The council was formed to make recommendations to the HHS secretary about different treatment options including medications and surgical procedures and aims to present the best information possible to doctors and patients as they make healthcare choices, said Carolyn Clancy, a physician who is director of the Agency for Healthcare Research and Quality. That information is too often lacking, she said during a teleconference.
Clancy was one of the members named to the new council. In addition, David Hunt, a physician who is chief medical officer in the Office of the National Coordinator, is on the council as well. Clancy, who ranked 30th on Modern Healthcares 100 Most Powerful People in Healthcare list last year, is involved in several national health information technology initiatives as well. Hunt is playing a duel role at the ONC, serving as interim director in the Office of Health Information Technology Adoption while the office seeks a permanent replacement for Karen Bell.
AHRQ will use $300 million of the allocated funds to extend its comparative-effectiveness research programs. The National Institutes of Health and HHS each receive $400 million in funding for research through the stimulus law. The federal council is required by the law to submit an operations plan by July 30 that outlines its priorities for the research spending.
In addition to Clancy and Hunt, the other 13 members of the council are: